Oncotelic Therapeutics (OTLC) News Today $0.03 +0.00 (+7.50%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024November 6, 2024 | globenewswire.comONCOTELIC PUBLISHED ITS FOURTH PUBLICATION ON TGFB2 THERAPEUTICSOctober 28, 2024 | finance.yahoo.comONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY & PRECLINICAL SUMMIT SAN DIEGO 2024October 24, 2024 | finance.yahoo.comAlibaba rises on report it will charge software service feeJuly 29, 2024 | uk.finance.yahoo.comProduct Manager Scott Myers to Present at 2nd Global Summit on Artificial IntelligenceJuly 29, 2024 | globenewswire.comONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGYJune 11, 2024 | globenewswire.comONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETINGMay 30, 2024 | globenewswire.comONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETINGMay 20, 2024 | globenewswire.comOncotelic Therapeutics Inc OTLCMay 19, 2024 | morningstar.comONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024May 16, 2024 | finance.yahoo.comLinkage of Cancer and Lupus in Gliomas PatientsMarch 25, 2024 | finance.yahoo.comLinkage of Cancer and Lupus in Gliomas PatientsMarch 25, 2024 | globenewswire.comInvitation to Participate in STOP-PC Clinical TrialMarch 4, 2024 | globenewswire.comOncotelic Therapeutics Stock (OTC:OTLC) Earnings Dates and Earning CallsFebruary 22, 2024 | benzinga.comOncotelic Therapeutics Strikes Material Definitive Legal AgreementFebruary 3, 2024 | msn.comLineage Cell Therapeutics Inc LCTXJanuary 23, 2024 | morningstar.comOncotelic Therapeutics Announces Opening of GMP Manufacturing PlantDecember 18, 2023 | finance.yahoo.comOncotelic Therapeutics, Inc.: Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial ResultsNovember 15, 2023 | finanznachrichten.deOncotelic Therapeutics reports Q3 resultsNovember 15, 2023 | msn.comOncotelic Reports Q3 2023 Compared to Q3 2022 Financial ResultsNovember 15, 2023 | finance.yahoo.comThe Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB:OTLC) Is Leading The ChargeSeptember 11, 2023 | benzinga.comThe Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB: OTLC) Is Helping Lead The ChargeSeptember 11, 2023 | benzinga.comOncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023August 25, 2023 | finance.yahoo.comSapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic CancerAugust 23, 2023 | finance.yahoo.comOncotelic Participating at 2023 BIO International ConventionMay 16, 2023 | finance.yahoo.comOncotelic Launches PDAO SEC ChatbotApril 24, 2023 | technews.tmcnet.comOncotelic Therapeutics reports FY resultsApril 20, 2023 | seekingalpha.comOncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model TechnologyApril 19, 2023 | finance.yahoo.comHigh Intra-Tumor TGF-ß2 Predicts Poor Survival in Pediatric Cancer of the BrainstemMarch 13, 2023 | technews.tmcnet.comOTLC Oncotelic Therapeutics, Inc.February 15, 2023 | seekingalpha.comOncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell CancerFebruary 6, 2023 | finance.yahoo.comOncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic CancerJanuary 25, 2023 | finance.yahoo.comOncotelic Issues Year End Message to ShareholdersDecember 28, 2022 | finance.yahoo.comOncotelic Initiates Clinical Trials Evaluating OT-101 against Pediatric GliomasNovember 8, 2022 | finance.yahoo.comOncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual MeetingSeptember 28, 2022 | finance.yahoo.comOncotelic Therapeutics, Inc. (OTLC)September 16, 2022 | sg.finance.yahoo.comOncotelic Presenting Data for OT101 Against Diffuse Intrinsic Pontine Glioma (DIPG) at the 2022 Society for Neuro-Oncology (SNO) Annual MeetingSeptember 14, 2022 | finance.yahoo.comOncotelic Therapeutics reports Q2 resultsAugust 23, 2022 | seekingalpha.comONCOTELIC REPORTS Q2 2022 COMPARED TO Q2 2021 FINANCIAL RESULTSAugust 22, 2022 | finance.yahoo.comOncotelic Participating at Biotechgate Digital PartneringAugust 17, 2022 | finance.yahoo.comOncotelic Announces Presentation of P001- OT-101 Phase 1/2 Trial in Pancreatic CancerJuly 12, 2022 | finance.yahoo.comOncotelic gets FDA nod for mid-stage trial design for lead asset and Keytruda comboMay 25, 2022 | seekingalpha.comOncotelic Therapeutics Receives FDA Clearance for Phase 2 Clinical Trial of OT-101/Pembroluzimab Combination for Mesothelioma (M201)May 25, 2022 | finance.yahoo.comONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 2021, PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATEMay 23, 2022 | finance.yahoo.comONCOTELIC ANNOUNCES US PATENT GRANT FOR CA4P AND OXI4503 COMBINATION WITH CHECKPOINT INHIBITORSMay 11, 2022 | finance.yahoo.comOncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical OfficerMay 3, 2022 | finance.yahoo.comONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATEApril 18, 2022 | finance.yahoo.comOncotelic to Present New Studies on its TGF-β Program at the American Association for Cancer Research (AACR) Annual Meeting 2022March 10, 2022 | finance.yahoo.comDr. Anthony E. Maida will be presenting at the Marcus Evans Evolution SummitMarch 3, 2022 | finance.yahoo.comOncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor ConferenceFebruary 24, 2022 | finance.yahoo.com Get Oncotelic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OTLC and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin OTLC Media Mentions By Week OTLC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTLC News Sentiment▼0.000.60▲Average Medical News Sentiment OTLC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTLC Articles This Week▼00▲OTLC Articles Average Week Get Oncotelic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OTLC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRLD News VTVT News XTNT News CASI News KZR News MRMD News OMGA News XCUR News ACAB News ESLA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OTLC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OTLC Stock Alerts